17 dec: Tjen 42.000 kr. på en times arbejde
17 dec: Blue Capital A/S - Nyt dansk K/S udbyderselskab med erfaren ejerk..
17-12-2010 13:18:52

Banks weigh on FTSE as Moody's cuts Ireland's rating

The London Stock Exchange building is seen in central London
Relateret indhold

By David Brett

LONDON (Reuters) - Banks pulled top shares lower around midday on Friday, as concerns over Ireland's debt situation weighed on the sector after Moody's slashed the country's credit rating.

By 11:39 a.m., the FTSE 100 was down 10.63 points, or 0.2 percent, at 5,870.49.

Banks were led lower by Royal Bank of Scotland (Royal Bank of Scotland Group P), down 2.2 percent, on persistent concerns over euro zone debt, as Moody's Investors Service cut Ireland's credit rating by five notches to Baa1 from Aa2 and said further downgrades could follow.

"Europe's sovereign debt problems are hampering the FTSE's progress," said Jimmy Yates, head of equities and CMC Markets.

"Until a firm resolution is agreed by EU leaders, London's blue chips will struggle to break above recent highs (5,907.10) before the year-end."

Elsewhere among the fallers, AstraZeneca (Astrazeneca PLC ORD SHS $0.25) slipped 5.3 percent after its new heart medicine Brilinta failed to win approval from U.S. regulators.

UK REITS RISE

FTSE 100 real estate investment trust companies British Land (British Land Company PLC ORD 2), Hammerson (Hammerson PLC ORD 25P) and Land Securities Group (Land Securities Group PLC ORD) rose 0.8-2.5 percent as Credit Suisse upgraded its stance on the sector to "overweight" in a strategy note.

Mid-cap UK real estate firms were also boosted as Barclays Capital started its coverage of three of the firms in the sector, Derwent London (Derwent London PLC ORD 5P), Capital & Counties and Great Portland Estates (Great Portland Estates PLC ORD), with an "overweight" stance, pushing the shares up 1.4-2.1 percent.

Software group Autonomy Corp climbed 2.7 percent, aided by an upgrade in its target price by Panmure Gordon in a note that highlighted strong results from U.S. tech firms.

Airplane parts maker GKN (GKN PLC ORD 10P) rose 0.9 percent, adding to gains of 3 percent made on Thursday, helped by an upgrade in rating from Societe Generale and ahead of a pre-Christmas trading statement.

On the second line, retailers suffered, with Dixons (Dixons Retail PLC ORD 2.5P) down 5.3 percent as UBS downgraded its rating on the electrical retailer to "neutral" from "buy" and kept its "underweight" stance on the non-food retail sector.

Fashion retailer SuperGroup (Supergroup PLC ORD 5P) was the top FTSE 250 loser, down 6.2 percent, extending losses since its first-half results on Wednesday.

There was no important British economic data due on Friday, but investors will keep an eye on U.S. November lead indicators, which are scheduled for release at 1500 GMT.

(Editing by Will Waterman)

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

DSV/Nykredit: Kursmål bliver hævet med 8 pct. før regnskab

28-04-2017 14:21:41
Nykredit hæver kursmålet for DSV-aktien til 400 kr. fra 370 kr. forud for transportkoncernens regnskab i næste uge.Banken vurderer, at DSV står stærkt på markedet og kan begynde at fokusere på organisk vækst, efter at det seneste år primært er gået med at integrere amerikanske UTI Worldwide, der blev købt sidste år for 9,5 mia. kr.- Vi har hævet vores estimater for de kommende år. Derudover har vi..

Novo/Nordea: Sanofi-regnskab indikerer lyspunkt på vækstmarkeder

28-04-2017 11:31:07
Kvartalsregnskabet fra Novo Nordisks store franske rival, Sanofi, vidner om, at diabetesforretningen har haft en en stærk udvikling på vækstmarkederne, mens salget er under pres i USA.Og det er en tendens, som Nordea regner med også kan slå igennem i Novos regnskabstal på onsdag. Det fremgår af et notat.Nordea understreger dog, at det langt fra er ligetil at drage paralleller fra Sanofis regnskab...

Novo-rival slår overskuds- og salgsforventninger i første kvartal - NY

28-04-2017 08:06:11
Den franske medicinalvirksomhed Sanofi, der er blandt Novo Nordisks største konkurrenter, er kommet ud af årets første tre måneder med en bedre indtjening end ventet.I første kvartal endte det justerede overskud per aktie (Business EPS, red.) på 1,42 euro, hvilket var højere end de 1,26 euro, som analytikerne ifølge Bloomberg News havde sat næsen op efter.Den samlede omsætning steg til 8,65 mia. e..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Royal Bank of Scotland G.. 265,14 4,6% Stigning i aktiekurs
GKN PLC ORD 10P 358,95 1,4% Stigning i aktiekurs
British Land Company PLC.. 658,77 -0,5% Fald i aktiekurs
Hammerson PLC ORD 25P 587,94 -1,4% Fald i aktiekurs
Land Securities Group PL.. 1.106,00 -1,1% Fald i aktiekurs
Astrazeneca PLC ORD SHS .. 4.637,18 -1,3% Fald i aktiekurs
Great Portland Estates P.. 698,69 -0,5% Fald i aktiekurs
Derwent London PLC ORD 5.. 2.972,88 -1,1% Fald i aktiekurs
Supergroup PLC ORD 5P 1.595,00 -0,5% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
30. april 2017 14:44:53
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseCandidateBuild_20170427.1 - EUROWEB7 - 2017-04-30 14:44:53 - 2017-04-30 14:44:53 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x